1.3 Canadian Pharmacy Regulatory Framework, NAPRA Standards, and Professional Legislation

1.3 Canadian Pharmacy Regulatory Framework, NAPRA Standards, and Professional Legislation

Exam Focus: Mastery of the National Association of Pharmacy Regulatory Authorities (NAPRA) Model Standards, provincial regulatory mandates, the National Drug Schedules (NDS), and federal controlled substance legislation under the Controlled Drugs and Substances Act (CDSA) is essential for Canadian pharmacy practice and represents a core component of the PEBC Evaluating Examination.

---

The Multi-Tiered Regulatory Architecture

Canadian pharmacy practice operates within a multi-tiered regulatory framework. Federal statutes govern drug manufacturing, product classification, and controlled substances; national associations harmonize standards across provinces; and provincial regulatory colleges hold direct statutory authority over licensed practitioners and pharmacy premises.

+-------------------------------------------------------------------------+
|                     CANADIAN REGULATORY ARCHITECTURE                    |
+-------------------------------------------------------------------------+
|  1. FEDERAL STATUTES (Health Canada)                                    |
|     * Food and Drugs Act & Regulations (Prescription Drug List)         |
|     * Controlled Drugs and Substances Act (NCR, BOTSR, Part G)          |
|                                |                                        |
|                                v                                        |
|  2. NATIONAL HARMONIZING BODY (NAPRA)                                   |
|     * National Drug Schedules (NDS Model: Schedules I, II, III)         |
|     * Model Standards of Practice & Compounding Quality Standards       |
|                                |                                        |
|                                v                                        |
|  3. PROVINCIAL REGULATORY AUTHORITIES (PRAs / Colleges of Pharmacy)     |
|     * Enact Provincial Pharmacy Acts and Regulations (Binding Law)      |
|     * Licensure of Pharmacists, Pharmacy Techs, and Pharmacy Premises   |
|     * Expanded Clinical Scopes (Minor Ailments, Prescribing, Injections)|
+-------------------------------------------------------------------------+

---

National Association of Pharmacy Regulatory Authorities (NAPRA)

The National Association of Pharmacy Regulatory Authorities (NAPRA) is a voluntary federation encompassing provincial and territorial pharmacy regulatory authorities across Canada, alongside Canadian Armed Forces Pharmacy Services.

Core Roles and Functions of NAPRA

• National Model Standards of Practice: Establishes harmonized competency frameworks, ethical standards, and practice benchmarks across jurisdictions.
• Compounding Standards: Formulates national standards for pharmacy compounding, including:
  • Model Standards for Pharmacy Compounding of Non-Sterile Preparations.
  • Model Standards for Pharmacy Compounding of Non-Hazardous Sterile Preparations.
  • Model Standards for Pharmacy Compounding of Hazardous Sterile Preparations.
• National Drug Schedules (NDS): Develops and maintains the national four-tier drug scheduling framework.
• Advisory Nature: NAPRA possesses no statutory regulatory power. Its model standards, compounding guidelines, and drug schedules become legally binding on practitioners only when formally adopted into law, regulation, or bylaw by individual provincial and territorial Pharmacy Regulatory Authorities.

---

Provincial Pharmacy Regulatory Authorities (PRAs / Colleges of Pharmacy)

Under the Canadian Constitution, professional regulation is a provincial responsibility. Each province and territory has established a Provincial Pharmacy Regulatory Authority (PRA) (such as the Ontario College of Pharmacists or College of Pharmacists of British Columbia), operating under provincial Regulated Health Professions Acts or Pharmacy Acts.

Mandate and Core Responsibilities

• Public Protection: The primary legal mandate of every PRA is to serve and protect the public interest, ensuring safe, competent, and ethical pharmacy care. (Professional advocacy is the mandate of separate associations, such as the Canadian Pharmacists Association [CPhA] or provincial advocacy bodies).
• Licensure and Registration: Establishing entry-to-practice qualifications and maintaining registers for pharmacists, pharmacy technicians, interns, and students.
• Premises Accreditation and Inspection: Licensing, inspecting, and regulating community, hospital, and compounding pharmacies.
• Quality Assurance: Administering continuing professional development programs, learning portfolio audits, and quality improvement programs.
• Complaints and Discipline: Investigating public complaints, conducting formal discipline hearings, and issuing sanctions (reprimands, fines, practice conditions, suspensions, or license revocations) for professional misconduct or incompetence.
• Expanded Scope of Practice: Provincial legislation governs clinical pharmacy scopes, which across Canada include:
  • Prescribing for minor ailments and self-limiting conditions.
  • Adapting, modifying, renewing, or extending existing prescriptions.
  • Administering vaccines and injectable medications via intramuscular and subcutaneous routes.
  • Ordering, receiving, and interpreting clinical laboratory tests.
  • Initiating smoking cessation therapies and emergency contraception.

---

The National Drug Scheduling System (NDS)

NAPRA developed the National Drug Schedules (NDS) to provide a consistent, risk-based framework for drug availability across Canada based on safety profiles, potential for misuse, and the degree of pharmacist intervention required.

+-------------------------------------------------------------------------+
|                     NATIONAL DRUG SCHEDULES (NDS)                       |
+-------------------------------------------------------------------------+
|  SCHEDULE I: Prescription Required                                      |
|  * Sold only pursuant to a valid prescription from authorized prescriber|
|  * Stored exclusively within the secure dispensary                      |
|  ---------------------------------------------------------------------  |
|  SCHEDULE II: Behind-the-Counter (BTC) / Pharmacist Intervention        |
|  * No prescription required; mandatory pharmacist assessment            |
|  * Stored in professional area with NO public self-selection access     |
|  ---------------------------------------------------------------------  |
|  SCHEDULE III: Pharmacy Self-Selection Area                             |
|  * Unrestricted public access within the licensed pharmacy boundary     |
|  * Pharmacist must be available on-site for consultation                |
|  ---------------------------------------------------------------------  |
|  UNSCHEDULED: Open Retail Sale                                          |
|  * Sold in any retail commercial outlet (grocery, convenience stores)   |
|  * Safe for broad self-selection with adequate package labeling         |
+-------------------------------------------------------------------------+

Detailed Scheduling Breakdown

Note on Quebec: The province of Quebec does not adhere to the NAPRA National Drug Schedules and establishes its own drug schedules under the Loi sur la pharmacie and the Code des professions.

---

Federal Controlled Substances: CDSA and Regulations

Medications with psychoactive properties, addiction liability, or potential for diversion are governed federally under the Controlled Drugs and Substances Act (CDSA).

1. Narcotic Control Regulations (NCR)

Governs drugs listed in the Schedule to the NCR (narcotics), divided into two primary operational classes:

A. Straight / Single-Entity Narcotics

• Definition: Any single-entity narcotic agent (e.g., morphine, hydromorphone, oxycodone, fentanyl, methadone, codeine alone), any narcotic combined with only one other active non-narcotic ingredient, or any parenteral narcotic formulation.
• Prescription Requirements: Must be ordered via a written or secure electronic prescription from an authorized practitioner. Verbal (telephone) orders are strictly prohibited.
• Refills: Refills are strictly PROHIBITED under the NCR (Section 37). Prescribers may authorize part-fills (installments) by specifying a total quantity, a specific part-fill quantity, and a defined refill interval (e.g., "Total 60 tablets: Dispense 15 tablets every 7 days").

B. Verbal Prescription Narcotics (VPN) / Narcotic Preparations

• Definition: Products containing one narcotic ingredient combined with two or more active, non-narcotic ingredients in recognized therapeutic amounts (e.g., Tylenol #3: acetaminophen $300\text{ mg}$ + caffeine $15\text{ mg}$ + codeine phosphate $30\text{ mg}$), and non-parenteral in formulation.
• Prescription Requirements: May be ordered via written prescription or authorized as a verbal (telephone) order by the prescriber.
• Refills: Refills are strictly PROHIBITED (Section 53). Part-fills/installments are permitted if explicit quantities and intervals are specified.

C. Exempted Codeine Products (OTC)

• Products containing up to $8\text{ mg}$ of codeine per solid dosage form (or $20\text{ mg}/30\text{ mL}$ in liquid) combined with two or more non-narcotic ingredients. Regulated as Schedule II (Behind-the-Counter) requiring pharmacist assessment.

2. Food and Drug Regulations – Part G (Controlled Drugs)

Governs drugs listed under Part G of the Food and Drug Regulations, divided into three parts:

• Part I: Amphetamines, methylphenidate, pentobarbital, secobarbital.
• Part II: Barbiturates (phenobarbital, butalbital), butorphanol.
• Part III: Anabolic steroids (testosterone, nandrolone).
• Prescription Requirements: Written or verbal orders permitted.
• Refills: Permitted ONLY if explicitly authorized by the prescriber in writing with specified refill intervals.

3. Benzodiazepines and Other Targeted Substances Regulations (BOTSR)

Governs targeted substances (all benzodiazepines such as lorazepam, diazepam, clonazepam, alprazolam, and non-benzodiazepine receptor agonists like zopiclone and zolpidem).

• Prescription Requirements: Written or verbal orders permitted.
• Refills: Refills are permitted if authorized by the prescriber.
• Maximum Refill Validity: All authorized refills expire exactly one (1) year (12 months) from the original date the prescription was written by the prescriber, regardless of remaining quantities.
• Prescription Transfers: A prescription for a targeted substance may be transferred only ONCE in its lifetime between pharmacies in Canada (unless sharing a centralized real-time database within the same corporate system as approved by the PRA).

---

Mandatory Loss, Theft, and Shortage Reporting Protocols

Under federal legislation (CDSA, NCR, and BOTSR), the pharmacist and designated pharmacy manager have strict legal obligations regarding unaccounted controlled substances:

1. Reporting Timeline: Any discovered theft, loss, or unexplainable shortage of narcotics, controlled drugs, or targeted substances must be reported to Health Canada's Office of Controlled Substances (OCS) within ten (10) calendar days of discovery.
2. Reporting Mechanism: Submitted via the official Health Canada Loss and Theft Report Form for Controlled Substances and Precursors (CS-FRM-001).
3. Police Notification: Local police services must be notified immediately in all cases involving robbery, burglary, or suspected criminal diversion.
4. Provincial College Notification: In accordance with provincial bylaws, the pharmacy manager must notify the provincial College of Pharmacists.
5. Record Retention: All records relating to the purchase, dispensing, loss, and destruction of narcotics and controlled substances must be retained in the pharmacy for a minimum of two (2) years under federal law (with provincial colleges mandating retention periods of 5 to 10 years).